Click for best price
AntiObesity Drugs Antiobesity Medication Market Size, Share 2022
Market Analysis and Insights: Global AntiObesity Drugs Antiobesity Medication Market
The global AntiObesity Drugs Antiobesity Medication market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global AntiObesity Drugs Antiobesity Medication market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global AntiObesity Drugs Antiobesity Medication market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global AntiObesity Drugs Antiobesity Medication market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global AntiObesity Drugs Antiobesity Medication market.
Global AntiObesity Drugs Antiobesity Medication Scope and Market Size
Anti-Obesity Drugs (Anti-obesity Medication) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Anti-Obesity Drugs (Anti-obesity Medication) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
by Drug Varieties
Prescription Drugs
OTC Drugs
by Acting
Peripherally Acting Anti-obesity Drugs
Centrally Acting Anti-obesity Drugs
Segment by Application
Childhood (0-6)
Juvenile (7-17)
Youth (18-40)
Middle Aged (41-60)
Elderly (Above 60)
By Company
Zafgan
Vivus
Shionogi
Sanofi
Rhythm Pharmaceuticals
Pfizer
Orexigen Therapeutics
Novo Nordisk
Norgine
Nalpropion Pharmaceuticals Inc.
Merck
GlaxoSmithKline
F.Hoffmann-La Roche
Eisai
Boehringer Ingelheim
Bayer AG
AstraZeneca
Arena Pharmaceuticals
Amylin
Alizyme
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes AntiObesity Drugs Antiobesity Medication product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of AntiObesity Drugs Antiobesity Medication, with price, sales, revenue, and global market share of AntiObesity Drugs Antiobesity Medication from 2019 to 2022.
Chapter 3, the AntiObesity Drugs Antiobesity Medication competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the AntiObesity Drugs Antiobesity Medication breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the AntiObesity Drugs Antiobesity Medication market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of AntiObesity Drugs Antiobesity Medication.
Chapter 13, 14, and 15, to describe AntiObesity Drugs Antiobesity Medication sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 AntiObesity Drugs Antiobesity Medication Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global Anti-Obesity Drugs (Anti-obesity Medication) Market Insights and Forecast to 2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
129 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Anti-Obesity Drugs (Anti-obesity Medication) Product Introduction
1.2 Market by Type
1.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Prescription Drugs
1.2.3 OTC Drugs
1.3 Market by Application
1.3.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Childhood (0-6)
1.3.3 Juvenile (7-17)
1.3.4 Youth (18-40)
1.3.5 Middle Aged (41-60)
1.3.6 Elderly (Above 60)
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Estimates and Forecasts 2017-2028
2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Estimates and Forecasts 2017-2028
2.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region
2.4.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region (2017-2022)
2.4.2 Global Sales Anti-Obesity Drugs (Anti-obesity Medication) by Region (2023-2028)
2.5 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Region
2.5.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Region (2017-2022)
2.5.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Manufacturers
3.1.1 Global Top Anti-Obesity Drugs (Anti-obesity Medication) Manufacturers by Sales (2017-2022)
3.1.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anti-Obesity Drugs (Anti-obesity Medication) in 2021
3.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Manufacturers
3.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Manufacturers (2017-2022)
3.2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Anti-Obesity Drugs (Anti-obesity Medication) Revenue in 2021
3.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type
4.1.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Historical Sales by Type (2017-2022)
4.1.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Forecasted Sales by Type (2023-2028)
4.1.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2017-2028)
4.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type
4.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Historical Revenue by Type (2017-2022)
4.2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Type (2017-2028)
4.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Type
4.3.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Type (2017-2022)
4.3.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application
5.1.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Historical Sales by Application (2017-2022)
5.1.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Forecasted Sales by Application (2023-2028)
5.1.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2017-2028)
5.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application
5.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Historical Revenue by Application (2017-2022)
5.2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Application (2017-2028)
5.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Application
5.3.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Application (2017-2022)
5.3.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Type
6.1.1 North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2017-2028)
6.1.2 North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2017-2028)
6.2 North America Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Application
6.2.1 North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2017-2028)
6.2.2 North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2017-2028)
6.3 North America Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country
6.3.1 North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2017-2028)
6.3.2 North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Type
7.1.1 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2017-2028)
7.1.2 Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2017-2028)
7.2 Europe Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Application
7.2.1 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2017-2028)
7.2.2 Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2017-2028)
7.3 Europe Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country
7.3.1 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2017-2028)
7.3.2 Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Type
8.1.1 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2017-2028)
8.1.2 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2017-2028)
8.2 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Application
8.2.1 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2017-2028)
8.2.2 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2017-2028)
8.3 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Region
8.3.1 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region (2017-2028)
8.3.2 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Type
9.1.1 Latin America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2017-2028)
9.1.2 Latin America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2017-2028)
9.2 Latin America Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Application
9.2.1 Latin America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2017-2028)
9.2.2 Latin America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2017-2028)
9.3 Latin America Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country
9.3.1 Latin America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2017-2028)
9.3.2 Latin America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Type
10.1.1 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2017-2028)
10.2 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Application
10.2.1 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2017-2028)
10.3 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country
10.3.1 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Zafgan
11.1.1 Zafgan Corporation Information
11.1.2 Zafgan Overview
11.1.3 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Zafgan Recent Developments
11.2 Vivus
11.2.1 Vivus Corporation Information
11.2.2 Vivus Overview
11.2.3 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Vivus Recent Developments
11.3 Shionogi
11.3.1 Shionogi Corporation Information
11.3.2 Shionogi Overview
11.3.3 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Shionogi Recent Developments
11.4 Sanofi
11.4.1 Sanofi Corporation Information
11.4.2 Sanofi Overview
11.4.3 Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sanofi Recent Developments
11.5 Rhythm Pharmaceuticals
11.5.1 Rhythm Pharmaceuticals Corporation Information
11.5.2 Rhythm Pharmaceuticals Overview
11.5.3 Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Rhythm Pharmaceuticals Recent Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pfizer Recent Developments
11.7 Orexigen Therapeutics
11.7.1 Orexigen Therapeutics Corporation Information
11.7.2 Orexigen Therapeutics Overview
11.7.3 Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Orexigen Therapeutics Recent Developments
11.8 Novo Nordisk
11.8.1 Novo Nordisk Corporation Information
11.8.2 Novo Nordisk Overview
11.8.3 Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Novo Nordisk Recent Developments
11.9 Norgine
11.9.1 Norgine Corporation Information
11.9.2 Norgine Overview
11.9.3 Norgine Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Norgine Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Norgine Recent Developments
11.10 Nalpropion Pharmaceuticals Inc.
11.10.1 Nalpropion Pharmaceuticals Inc. Corporation Information
11.10.2 Nalpropion Pharmaceuticals Inc. Overview
11.10.3 Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Nalpropion Pharmaceuticals Inc. Recent Developments
11.11 Merck
11.11.1 Merck Corporation Information
11.11.2 Merck Overview
11.11.3 Merck Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Merck Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Merck Recent Developments
11.12 GlaxoSmithKline
11.12.1 GlaxoSmithKline Corporation Information
11.12.2 GlaxoSmithKline Overview
11.12.3 GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 GlaxoSmithKline Recent Developments
11.13 F.Hoffmann-La Roche
11.13.1 F.Hoffmann-La Roche Corporation Information
11.13.2 F.Hoffmann-La Roche Overview
11.13.3 F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 F.Hoffmann-La Roche Recent Developments
11.14 Eisai
11.14.1 Eisai Corporation Information
11.14.2 Eisai Overview
11.14.3 Eisai Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Eisai Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Eisai Recent Developments
11.15 Boehringer Ingelheim
11.15.1 Boehringer Ingelheim Corporation Information
11.15.2 Boehringer Ingelheim Overview
11.15.3 Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Boehringer Ingelheim Recent Developments
11.16 Bayer AG
11.16.1 Bayer AG Corporation Information
11.16.2 Bayer AG Overview
11.16.3 Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Bayer AG Recent Developments
11.17 AstraZeneca
11.17.1 AstraZeneca Corporation Information
11.17.2 AstraZeneca Overview
11.17.3 AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 AstraZeneca Recent Developments
11.18 Arena Pharmaceuticals
11.18.1 Arena Pharmaceuticals Corporation Information
11.18.2 Arena Pharmaceuticals Overview
11.18.3 Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Arena Pharmaceuticals Recent Developments
11.19 Amylin
11.19.1 Amylin Corporation Information
11.19.2 Amylin Overview
11.19.3 Amylin Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Amylin Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Amylin Recent Developments
11.20 Alizyme
11.20.1 Alizyme Corporation Information
11.20.2 Alizyme Overview
11.20.3 Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Alizyme Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Anti-Obesity Drugs (Anti-obesity Medication) Industry Chain Analysis
12.2 Anti-Obesity Drugs (Anti-obesity Medication) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Anti-Obesity Drugs (Anti-obesity Medication) Production Mode & Process
12.4 Anti-Obesity Drugs (Anti-obesity Medication) Sales and Marketing
12.4.1 Anti-Obesity Drugs (Anti-obesity Medication) Sales Channels
12.4.2 Anti-Obesity Drugs (Anti-obesity Medication) Distributors
12.5 Anti-Obesity Drugs (Anti-obesity Medication) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Anti-Obesity Drugs (Anti-obesity Medication) Industry Trends
13.2 Anti-Obesity Drugs (Anti-obesity Medication) Market Drivers
13.3 Anti-Obesity Drugs (Anti-obesity Medication) Market Challenges
13.4 Anti-Obesity Drugs (Anti-obesity Medication) Market Restraints
14 Key Findings in The Global Anti-Obesity Drugs (Anti-obesity Medication) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Prescription Drugs
Table 3. Major Manufacturers of OTC Drugs
Table 4. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region (2017-2022) & (K Units)
Table 7. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Region (2017-2022)
Table 8. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region (2023-2028) & (K Units)
Table 9. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Region (2023-2028)
Table 10. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Region (2017-2022)
Table 12. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Region (2023-2028)
Table 14. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Share by Manufacturers (2017-2022)
Table 16. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Manufacturers (2017-2022)
Table 18. Anti-Obesity Drugs (Anti-obesity Medication) Price by Manufacturers (2017-2022) &(USD/Unit)
Table 19. Global Anti-Obesity Drugs (Anti-obesity Medication) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Anti-Obesity Drugs (Anti-obesity Medication) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Obesity Drugs (Anti-obesity Medication) as of 2021)
Table 21. Anti-Obesity Drugs (Anti-obesity Medication) Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Anti-Obesity Drugs (Anti-obesity Medication) Product Offered
Table 23. Date of Manufacturers Enter into Anti-Obesity Drugs (Anti-obesity Medication) Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2017-2022) & (K Units)
Table 26. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2023-2028) & (K Units)
Table 27. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Share by Type (2017-2022)
Table 28. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Share by Type (2023-2028)
Table 29. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Type (2017-2022)
Table 32. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Type (2023-2028)
Table 33. Anti-Obesity Drugs (Anti-obesity Medication) Price by Type (2017-2022) & (USD/Unit)
Table 34. Global Anti-Obesity Drugs (Anti-obesity Medication) Price Forecast by Type (2023-2028) & (USD/Unit)
Table 35. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2017-2022) & (K Units)
Table 36. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2023-2028) & (K Units)
Table 37. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Share by Application (2017-2022)
Table 38. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Share by Application (2023-2028)
Table 39. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Application (2017-2022)
Table 42. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Application (2023-2028)
Table 43. Anti-Obesity Drugs (Anti-obesity Medication) Price by Application (2017-2022) & (USD/Unit)
Table 44. Global Anti-Obesity Drugs (Anti-obesity Medication) Price Forecast by Application (2023-2028) & (USD/Unit)
Table 45. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2017-2022) & (K Units)
Table 46. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2023-2028) & (K Units)
Table 47. North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2017-2022) & (K Units)
Table 50. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2023-2028) & (K Units)
Table 51. North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2017-2022) & (K Units)
Table 54. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2023-2028) & (K Units)
Table 55. North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2017-2022) & (K Units)
Table 58. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2023-2028) & (K Units)
Table 59. Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2017-2022) & (K Units)
Table 62. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2023-2028) & (K Units)
Table 63. Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2017-2022) & (K Units)
Table 66. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2023-2028) & (K Units)
Table 67. Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2023-2028) & (US$ Million)
Table 105. Zafgan Corporation Information
Table 106. Zafgan Description and Major Businesses
Table 107. Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 108. Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Zafgan Recent Developments
Table 110. Vivus Corporation Information
Table 111. Vivus Description and Major Businesses
Table 112. Vivus Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 113. Vivus Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Vivus Recent Developments
Table 115. Shionogi Corporation Information
Table 116. Shionogi Description and Major Businesses
Table 117. Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 118. Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Shionogi Recent Developments
Table 120. Sanofi Corporation Information
Table 121. Sanofi Description and Major Businesses
Table 122. Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 123. Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Sanofi Recent Developments
Table 125. Rhythm Pharmaceuticals Corporation Information
Table 126. Rhythm Pharmaceuticals Description and Major Businesses
Table 127. Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 128. Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Rhythm Pharmaceuticals Recent Developments
Table 130. Pfizer Corporation Information
Table 131. Pfizer Description and Major Businesses
Table 132. Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 133. Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Pfizer Recent Developments
Table 135. Orexigen Therapeutics Corporation Information
Table 136. Orexigen Therapeutics Description and Major Businesses
Table 137. Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 138. Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Orexigen Therapeutics Recent Developments
Table 140. Novo Nordisk Corporation Information
Table 141. Novo Nordisk Description and Major Businesses
Table 142. Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 143. Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Novo Nordisk Recent Developments
Table 145. Norgine Corporation Information
Table 146. Norgine Description and Major Businesses
Table 147. Norgine Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 148. Norgine Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Norgine Recent Developments
Table 150. Nalpropion Pharmaceuticals Inc. Corporation Information
Table 151. Nalpropion Pharmaceuticals Inc. Description and Major Businesses
Table 152. Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 153. Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Nalpropion Pharmaceuticals Inc. Recent Developments
Table 155. Merck Corporation Information
Table 156. Merck Description and Major Businesses
Table 157. Merck Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 158. Merck Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Merck Recent Developments
Table 160. GlaxoSmithKline Corporation Information
Table 161. GlaxoSmithKline Description and Major Businesses
Table 162. GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 163. GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. GlaxoSmithKline Recent Developments
Table 165. F.Hoffmann-La Roche Corporation Information
Table 166. F.Hoffmann-La Roche Description and Major Businesses
Table 167. F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 168. F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. F.Hoffmann-La Roche Recent Developments
Table 170. Eisai Corporation Information
Table 171. Eisai Description and Major Businesses
Table 172. Eisai Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 173. Eisai Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Eisai Recent Developments
Table 175. Boehringer Ingelheim Corporation Information
Table 176. Boehringer Ingelheim Description and Major Businesses
Table 177. Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 178. Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. Boehringer Ingelheim Recent Developments
Table 180. Bayer AG Corporation Information
Table 181. Bayer AG Description and Major Businesses
Table 182. Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 183. Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. Bayer AG Recent Developments
Table 185. AstraZeneca Corporation Information
Table 186. AstraZeneca Description and Major Businesses
Table 187. AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 188. AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
Table 189. AstraZeneca Recent Developments
Table 190. Arena Pharmaceuticals Corporation Information
Table 191. Arena Pharmaceuticals Description and Major Businesses
Table 192. Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 193. Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
Table 194. Arena Pharmaceuticals Recent Developments
Table 195. Amylin Corporation Information
Table 196. Amylin Description and Major Businesses
Table 197. Amylin Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 198. Amylin Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
Table 199. Amylin Recent Developments
Table 200. Alizyme Corporation Information
Table 201. Alizyme Description and Major Businesses
Table 202. Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 203. Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
Table 204. Alizyme Recent Developments
Table 205. Key Raw Materials Lists
Table 206. Raw Materials Key Suppliers Lists
Table 207. Anti-Obesity Drugs (Anti-obesity Medication) Distributors List
Table 208. Anti-Obesity Drugs (Anti-obesity Medication) Customers List
Table 209. Anti-Obesity Drugs (Anti-obesity Medication) Market Trends
Table 210. Anti-Obesity Drugs (Anti-obesity Medication) Market Drivers
Table 211. Anti-Obesity Drugs (Anti-obesity Medication) Market Challenges
Table 212. Anti-Obesity Drugs (Anti-obesity Medication) Market Restraints
Table 213. Research Programs/Design for This Report
Table 214. Key Data Information from Secondary Sources
Table 215. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Obesity Drugs (Anti-obesity Medication) Product Picture
Figure 3. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Type in 2021 & 2028
Figure 3. Prescription Drugs Product Picture
Figure 4. OTC Drugs Product Picture
Figure 5. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Application in 2021 & 2028
Figure 6. Childhood (0-6)
Figure 7. Juvenile (7-17)
Figure 8. Youth (18-40)
Figure 9. Middle Aged (41-60)
Figure 10. Elderly (Above 60)
Figure 11. Anti-Obesity Drugs (Anti-obesity Medication) Report Years Considered
Figure 12. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales 2017-2028 (K Units)
Figure 13. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue 2017-2028 (US$ Million)
Figure 15. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Region (2017-2022)
Figure 17. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Region (2023-2028)
Figure 18. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales YoY (2017-2028) & (K Units)
Figure 19. North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Anti-Obesity Drugs (Anti-obesity Medication) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Anti-Obesity Drugs (Anti-obesity Medication) in the World: Market Share by Anti-Obesity Drugs (Anti-obesity Medication) Revenue in 2021
Figure 30. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2017-2028)
Figure 32. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Type (2017-2028)
Figure 33. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2017-2028)
Figure 34. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Application (2017-2028)
Figure 35. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2017-2028)
Figure 36. North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Type (2017-2028)
Figure 37. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2017-2028)
Figure 38. North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Application (2017-2028)
Figure 39. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Share by Country (2017-2028)
Figure 40. North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Country (2017-2028)
Figure 41. U.S. Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2017-2028)
Figure 44. Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Type (2017-2028)
Figure 45. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2017-2028)
Figure 46. Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Application (2017-2028)
Figure 47. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Share by Country (2017-2028)
Figure 48. Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Country (2017-2028)
Figure 49. Germany Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2017-2028) & (US$ Million)
Figure 50. France Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Region (2017-2028)
Figure 60. China Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2017-2028) & (US$ Million)
Figure 63. India Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2017-2028) & (US$ Million)
Figure 65. China Taiwan Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2017-2028)
Figure 70. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2017-2028)
Figure 72. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Sales Share by Country (2017-2028)
Figure 74. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Country (2017-2028)
Figure 75. Mexico Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Country (2017-2028)
Figure 84. Turkey Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Anti-Obesity Drug
